Adam Goulburn is a Senior Associate with Lux Capital, based in the firm’s New York headquarters. Adam concentrates on investments within the healthcare and life science sectors. Adam focuses on broad investment opportunities in healthcare IT, services, mobile health and therapeutics. Adam has worked extensively with a number of Lux portfolio companies including Kyruus, Kala Pharmaceuticals and Genocea Biosciences. He is also a mentor for healthcare IT incubators Blueprint Health and Healthbox. Before joining Lux, Adam was a Postdoctoral Fellow of Neuroscience at Weill Cornell Medical College, researching regenerative medicine in association with brain disorders. Originally from Australia, Adam has dual undergraduate degrees in Commerce and Science and subsequently completed his PhD at the Australian Stem Cell Centre. He has published in numerous peer reviewed scientific journals.